While people across the world wait for news of treatments and vaccines for COVID-19, attention is also being given to antibody protection.  Although antibodies may provide significant protection from getting infected with the virus again, researchers are still determining how much protection antibodies may provide or how long this protection may last, if at all. A major new study in Spain found no evidence of widespread immunity to the virus, suggesting that people who experience mild symptoms do not have long-lasting protection.